Literature DB >> 15278009

Molecular mechanisms and clinical applications of ginseng root for cardiovascular disease.

Wei Zhou1, Hong Chai, Peter H Lin, Alan B Lumsden, Qizhi Yao, Changyi Johnny Chen.   

Abstract

Ginseng root is used extensively in traditional Chinese medicine for its alleged tonic effect and possible curative and restorative properties. There are increasing evidences in the literature on the potential role of ginseng in treating cardiovascular diseases. We herein examine the history of ginseng usage and review the current literature on a myriad pharmacological function of ginseng on the cardiovascular system. From the published studies involving cell cultures and animal models, ginseng is shown to have potential benefits on the cardiovascular system through diverse mechanisms, including antioxidant, modifying vasomotor function, reducing platelet adhesion, influencing ion channels, altering autonomic neurotransmitters release, improving lipid profiles, and involving in glucose metabolism and glycemic control. In addition, the relevant clinical trials regarding the effects of ginseng on the cardiovascular disease are summarized, particularly in managing hypertension and improving cardiovascular function. Finally, the controversies in the literature and the possible adverse interactions between ginseng and other drugs are discussed. This review underscores the potential benefit effects of ginseng on cardiovascular diseases, highlights the gaps in our current research, and emphasizes the necessity for more rigorous systemic investigation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15278009

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  22 in total

1.  Ginsenoside Rg1 inhibits autophagy in H9c2 cardiomyocytes exposed to hypoxia/reoxygenation.

Authors:  Zi-Long Zhang; Yan Fan; Mei-Lin Liu
Journal:  Mol Cell Biochem       Date:  2012-02-21       Impact factor: 3.396

2.  An essential role of Nrf2 in American ginseng-mediated anti-oxidative actions in cardiomyocytes.

Authors:  Jinqing Li; Tomonaga Ichikawa; Yu Jin; Lorne J Hofseth; Prakash Nagarkatti; Mitzi Nagarkatti; Anthony Windust; Taixing Cui
Journal:  J Ethnopharmacol       Date:  2010-05-04       Impact factor: 4.360

3.  Ginsenoside Rb1 attenuates homocysteine-augmented guidewire injury-induced intimal hyperplasia in mice.

Authors:  Hong Chai; Yanlan Dong; Xinwen Wang; Wei Zhou
Journal:  J Surg Res       Date:  2008-08-15       Impact factor: 2.192

4.  Safety monitoring of herb-drug interactions: a component of pharmacovigilance.

Authors:  Souad Skalli; Rachida Soulaymani Bencheikh
Journal:  Drug Saf       Date:  2012-10-01       Impact factor: 5.606

Review 5.  Potential neuroprotective activity of Ginseng in Parkinson's disease: a review.

Authors:  Elena González-Burgos; Carlos Fernandez-Moriano; M Pilar Gómez-Serranillos
Journal:  J Neuroimmune Pharmacol       Date:  2014-10-29       Impact factor: 4.147

6.  In vivo assessment of the effects of ginsenoside Rb1 on intimal hyperplasia in ApoE knockout mice.

Authors:  Hong Chai; Geoff Schultz; Kamran Aghaie; Wei Zhou
Journal:  J Surg Res       Date:  2010-02-11       Impact factor: 2.192

Review 7.  Ginseng compounds: an update on their molecular mechanisms and medical applications.

Authors:  Jian-Ming Lü; Qizhi Yao; Changyi Chen
Journal:  Curr Vasc Pharmacol       Date:  2009-07       Impact factor: 2.719

8.  Roles and mechanisms of human immunodeficiency virus protease inhibitor ritonavir and other anti-human immunodeficiency virus drugs in endothelial dysfunction of porcine pulmonary arteries and human pulmonary artery endothelial cells.

Authors:  Xinwen Wang; Hong Chai; Peter H Lin; Qizhi Yao; Changyi Chen
Journal:  Am J Pathol       Date:  2009-02-13       Impact factor: 4.307

9.  Low-dose ginseng (Panax quinquefolium) modulates the course and magnitude of the antibody response to vaccination against equid herpesvirus I in horses.

Authors:  Wendy Pearson; Semir Omar; Andrew F Clarke
Journal:  Can J Vet Res       Date:  2007-07       Impact factor: 1.310

10.  Highly active antiretroviral therapy drugs inhibit in vitro cholesterol efflux from human macrophage-derived foam cells.

Authors:  Xinwen Wang; Dan Liao; Peter H Lin; Qizhi Yao; Changyi Chen
Journal:  Lab Invest       Date:  2009-09-21       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.